Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 9
2009 18
2010 15
2011 11
2012 11
2013 5
2014 5
2015 3
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 20926546

70 results

Results by year

Filters applied: . Clear all
Page 1
Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients.
Ruzzo A, Canestrari E, Galluccio N, Santini D, Vincenzi B, Tonini G, Magnani M, Graziano F. Ruzzo A, et al. Ann Oncol. 2011 Jan;22(1):234-235. doi: 10.1093/annonc/mdq472. Epub 2010 Oct 6. Ann Oncol. 2011. PMID: 20926546 Free article. No abstract available.
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy.
Zhang W, Winder T, Ning Y, Pohl A, Yang D, Kahn M, Lurje G, LaBonte MJ, Wilson PM, Gordon MA, Hu-Lieskovan S, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ. Zhang W, et al. Ann Oncol. 2011 Jan;22(1):104-109. doi: 10.1093/annonc/mdq315. Epub 2010 Jul 5. Ann Oncol. 2011. PMID: 20603437 Free PMC article. Clinical Trial.
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan.
Graziano F, Canestrari E, Loupakis F, Ruzzo A, Galluccio N, Santini D, Rocchi M, Vincenzi B, Salvatore L, Cremolini C, Spoto C, Catalano V, D'Emidio S, Giordani P, Tonini G, Falcone A, Magnani M. Graziano F, et al. Pharmacogenomics J. 2010 Oct;10(5):458-64. doi: 10.1038/tpj.2010.9. Epub 2010 Feb 23. Pharmacogenomics J. 2010. PMID: 20177422 Clinical Trial.
[KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma].
Dubská L, Vyskocilová M, Nenutil R, Valík D, Knoflícková D, Fabian P, Kocáková I, Demlová R, Beránek M, Drastíková M, Vosmiková H, Bóday A, Horká K, Símová J, Drábek J, Ehrmann J, Hajdúch M, Matejcková M, Síma R, Tvrdík D, Povýsil C, Ryska A. Dubská L, et al. Cas Lek Cesk. 2011;150(6):321-6. Cas Lek Cesk. 2011. PMID: 21751504 Review. Czech.
Targeting EGFR in colorectal cancer.
Messersmith WA, Ahnen DJ. Messersmith WA, et al. N Engl J Med. 2008 Oct 23;359(17):1834-6. doi: 10.1056/NEJMe0806778. N Engl J Med. 2008. PMID: 18946069 No abstract available.
70 results